- Home
- AIXI vs DYAI Comparison
AIXI vs DYAI Comparison
Compare AIXI & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIXI
- DYAI
- Stock Information
- Founded
- AIXI 2001
- DYAI 1979
- Country
- AIXI China
- DYAI United States
- Employees
- AIXI N/A
- DYAI N/A
- Industry
- AIXI Computer Software: Prepackaged Software
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AIXI Technology
- DYAI Health Care
- Exchange
- AIXI Nasdaq
- DYAI Nasdaq
- Market Cap
- AIXI 31.2M
- DYAI 28.3M
- IPO Year
- AIXI 2023
- DYAI 2004
- Fundamental
- Price
- AIXI $2.00
- DYAI $1.00
- Analyst Decision
- AIXI
- DYAI Strong Buy
- Analyst Count
- AIXI 0
- DYAI 1
- Target Price
- AIXI N/A
- DYAI $6.00
- AVG Volume (30 Days)
- AIXI 190.6K
- DYAI 63.2K
- Earning Date
- AIXI 05-15-2025
- DYAI 08-12-2025
- Dividend Yield
- AIXI N/A
- DYAI N/A
- EPS Growth
- AIXI N/A
- DYAI N/A
- EPS
- AIXI N/A
- DYAI N/A
- Revenue
- AIXI $70,314,315.00
- DYAI $3,554,344.00
- Revenue This Year
- AIXI $26.84
- DYAI $22.56
- Revenue Next Year
- AIXI N/A
- DYAI $30.95
- P/E Ratio
- AIXI N/A
- DYAI N/A
- Revenue Growth
- AIXI 18.84
- DYAI 57.59
- 52 Week Low
- AIXI $1.81
- DYAI $0.91
- 52 Week High
- AIXI $8.31
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- AIXI 39.38
- DYAI 46.85
- Support Level
- AIXI $1.81
- DYAI $0.91
- Resistance Level
- AIXI $2.52
- DYAI $1.02
- Average True Range (ATR)
- AIXI 0.28
- DYAI 0.05
- MACD
- AIXI -0.03
- DYAI 0.01
- Stochastic Oscillator
- AIXI 26.74
- DYAI 35.07
About AIXI XIAO-I Corporation
XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.